Yahoo
NasdaqGM - Nasdaq Real Time Price USD

Intellia Therapeutics, Inc. (NTLA)

12.47 -0.76 (-5.74%)
At close: 4:00:00 PM EDT
12.45 -0.02 (-0.16%)
After hours: 5:03:14 PM EDT
Trade NTLA on Coinbase
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
59,506
67,671
57,877
36,275
52,121
Operating Expense
482,985
508,661
592,140
551,566
510,285
Operating Income
-423,479
-440,990
-534,263
-515,291
-458,164
Net Non Operating Interest Income Expense
24,192
29,195
47,807
49,832
8,542
Other Income Expense
-688
-899
-32,565
-15,733
-24,564
Pretax Income
-399,975
-412,694
-519,021
-481,192
-474,186
Net Income Common Stockholders
-399,975
-412,694
-519,021
-481,192
-474,186
Diluted NI Available to Com Stockholders
-399,975
-412,694
-519,021
-481,192
-474,186
Basic EPS
-3.34
-3.81
-5.25
-5.42
-6.16
Diluted EPS
-3.34
-3.81
-5.25
-5.42
-6.16
Basic Average Shares
119,596
108,376
98,849
88,770
76,972
Diluted Average Shares
119,596
108,376
98,849
88,770
76,972
Total Operating Income as Reported
-423,479
-440,990
-534,263
-515,291
-458,164
Total Expenses
482,985
508,661
592,140
551,566
510,285
Net Income from Continuing & Discontinued Operation
-399,975
-412,694
-519,021
-481,192
-474,186
Normalized Income
-399,287
-411,795
-486,456
-481,092
-460,701
Interest Income
24,192
29,195
47,807
49,832
8,542
Net Interest Income
24,192
29,195
47,807
49,832
8,542
EBIT
-423,479
-440,990
-534,263
-515,291
-458,164
EBITDA
-408,244
-425,067
-523,978
-506,315
-450,592
Reconciled Depreciation
15,235
15,923
10,285
8,976
7,572
Net Income from Continuing Operation Net Minority Interest
-399,975
-412,694
-519,021
-481,192
-474,186
Total Unusual Items Excluding Goodwill
-688
-899
-32,565
-100
-13,485
Total Unusual Items
-688
-899
-32,565
-100
-13,485
Normalized EBITDA
-407,556
-424,168
-491,413
-506,215
-437,107
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2022 - 5/6/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: